Supplemental Figure 7. Inhibition of EZH2 with Tazemetostat upregulates GD2 expression in MED-411 FHTC (G3 subgroup) MB cells.
No takes yet. Share an insight, caveat, or question.
Ciccone et al. (2024) studied this question.